Its primary applications in cancer immunotherapy, particularly modulating the PD-1/PD-L1 pathway and engineering immune-specialized T cells, are pivotal for fine-tuning immunotherapy, amplifying T-cell activation, and circumventing the immune evasion strategies employed by cancer cells [17,23,85,110]. Here, PDCD1 is linked to cancer.